Table 1.
Characteristics of subjects after excluding subjects with missing values
| NMIBC (n = 603) | |
|---|---|
| Age | |
| Median (Q1, Q3) | 66 (57,71) |
| Sex | |
| Male | 457 (75.8%) |
| Female | 146 (24.2%) |
| Tumor grade | |
| Grade 1 | 290 (48.1%) |
| Grade 2 | 162 (26.9%) |
| Grade 3 | 125 (20.7%) |
| Grade 4 | 26 (4.3%) |
| Smoking status | |
| Never | 103 (17.1%) |
| Ever | 500 (82.9%) |
| BCG: immunotherapy | |
| No | 514 (85.2%) |
| Yes | 89 (14.8%) |
| NLR | |
| Median (Q1, Q3) | 1.97 (1.40, 2.93) |
| 10-year dead status | |
| Alive | 423 (70.1%) |
| Deceased | 180 (29.9%) |
| 10-year survival | |
| Median (Q1, Q3) | 120.0 (105, 120) |
| 10-year recurrence status | |
| No | 193 (32.0%) |
| Yes | 295 (48.9%) |
| Missing | 115 (19.1%) |
| 10-year recurrence | |
| Median (Q1, Q3) | 17.7 (6.9, 67.1) |
| Missing | 115 |
Exclude subjects with missing values in muscle-invasive status, pathology reviewing status, tumor grade, smoking status, or pack-years